Modelling fragile X syndrome in the laboratory setting: A behavioral perspective

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Fragile X syndrome (FXS) is the leading inherited cause of intellectual disability and a frequent genetic cause of autism spectrum disorders.
• FXS results from the absence of the Fragile X Mental Retardation Protein (FMRP), impacting synaptic plasticity and neuronal development.
• Clinical manifestations include intellectual disability, social deficits, repetitive behaviors, and communication impairments.

Purpose of the Study:

• To emphasize the significance of developmental behavioral phenotyping in animal models of FXS.
• To bridge the gap between clinical FXS behavioral characteristics and laboratory-based, developmentally appropriate behavioral readouts.
• To review current progress, challenges, and future directions in modeling FXS behaviors in animals.

Main Methods:

• Reviewing the behavioral features, diagnostic criteria, and pharmacotherapy of FXS.
• Outlining the translation of clinical FXS behaviors into specific animal model readouts across development.
• Analyzing existing research on behavioral phenotyping in FXS animal models.

Main Results:

• Behavioral phenotyping in animal models is essential for identifying potential therapeutic targets for FXS.
• Developmentally-specific behavioral assessments are critical for accurate modeling of FXS.
• Translating clinical observations into robust animal models facilitates treatment discovery.

Conclusions:

• Behavioral phenotyping of FXS animal models from a developmental viewpoint is vital for advancing research.
• Understanding the developmental trajectory of behaviors in FXS models aids in the search for effective interventions.
• This approach is fundamental for the successful development of novel treatments for Fragile X syndrome.